SELECTIVE INSURANCE GROUP, INC (SIGI): what the price requires

At today's price, SELECTIVE INSURANCE GROUP, INC (SIGI) is priced for 11.7% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/SIGI

Headline

FieldValue
TickerSIGI
CompanySELECTIVE INSURANCE GROUP, INC
Current price$97.73/sh
CompositionStandard Commercial Lines 71% / Standard Personal Lines 8% / E&S Lines 11% / Investments 10%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed11.7%
Return on equity now13.4%
ROE gap-1.7pp
Price-to-book1.73x

Solve inputs: computed at a 8.5% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.7pp.

How unusual the bet is: within-range

ReferenceValue
vs own history+0.84σ
cohort percentile (of 80 peers)43
sustained it ~10 years at this level71%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.04x3expensive
Earnings0.83x2justifies
Relative0.38x3justifies
Growth1.21x1expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.3%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$106.680.92xyesTBVPS $59.18 × 1.80x (ROE (TTM) 12.7% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$89.761.09xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.2x / 11.0x / 12.8x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$81.181.20xyesBV/sh $59.31, ROE (TTM) 12.7%, ke 9.3%
Two-Stage Excess ReturnAsset$94.261.04xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$80.601.21xyesRev $5.4B, growth 9% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$255.850.38xyesEPS $7.31, growth 35% (input: historical EPS growth), PEG=0.37 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$98.770.99xyes√(22.5 × EPS $7.31 × BVPS $59.31) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$235.870.41xyesEPS $7.31 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$274.130.36xyesEPS $7.31 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$79.031.24xyesEPS $7.31 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-0.1%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The single most decisive number for an insurer is the return it earns on its capital, and Selective has been earning about 13.4% on equity, comfortably above its cost of capital. That is the whole game. An insurer that consistently earns more on its capital than the capital costs creates value every year it does so, and the price today asks it to sustain a return near 11.4%, below what it has been delivering. The bull case is that the gap is conservative: a company earning 13.4% is being priced for 11.4%, leaving room if underwriting discipline holds.

The business mix is built for that discipline. Selective leads with standard commercial lines, the segment where its underwriting department "oversees our underwriting philosophy and guidelines for each market size, SBU, and line of business", and supplements it with an excess-and-surplus book that writes risks "standard line carriers have declined to write" and that is exempt from much standard form and rate regulation. The E&S line carried an average 2024 premium per policyholder of approximately $5,300, a smaller, harder-to-write book that tends to price better in a firm market. The company also wraps risk-management services around its commercial customers, giving agents and policyholders "on-demand access to a curated selection of self-service risk management resources", which is the kind of value-add that helps retain accounts and supports pricing.

The investment side is the quiet second engine. A P&C insurer holds float, the premiums collected before claims are paid, and invests it, and Selective's full-year 2026 guidance points to after-tax net investment income of $465 million. Rising portfolio yields lift that income without any change to underwriting, so the same book of business earns more as bonds roll into higher-rate paper. With the share count essentially flat and the company returning capital through dividends, the combination of disciplined underwriting and a growing investment yield is what lets an insurer earning 13.4% on equity keep compounding book value per share. The price is paying for less than that.

Bear Case

Reserve adequacy is the soft ground under every property-and-casualty insurer, and it is where the bear case for Selective starts. An insurer books a profit today on its estimate of claims that will be paid years from now, and the 10-K is candid that "the ultimate loss and loss expense ratios may differ from current estimates." When those estimates prove light, the company strengthens reserves and prior-year profit gets clawed back. The most recent quarter showed no net prior-year casualty reserve development, which is reassuring, but the earnings call carried caution on reserve strengthening and personal-lines challenges, and casualty reserves in particular have been a sector-wide source of negative surprises. A return on equity of 13.4% built partly on reserves that later prove inadequate is not 13.4%.

The earnings quality question feeds the valuation. The price assumes a sustained return on equity near 11.4% and pays about 1.6 times book to get it, and the historical record is that only about 72% of firms earning this kind of return held it for a decade at this level. Catastrophe exposure is the visible version of the risk: the first quarter of 2026 absorbed 6.2 points of catastrophe losses, pushing the combined ratio to 98.3%, meaning the company kept barely two cents of underwriting profit per premium dollar before investment income. A heavier catastrophe year, a softening pricing cycle, or further reserve strengthening would each pull the realized return below the 11.4% the price assumes, and a regional insurer with concentrated geographic exposure feels weather more than a national diversified carrier.

The valuation itself sits in the lower half of the peer group's price-to-book, which the bear reads two ways. It can mean the stock is cheap, or it can mean the market assigns Selective a lower-quality multiple than carriers like W.R. Berkley or The Hartford for a reason, whether that is reserve risk, geographic concentration, or a personal-lines book under pressure. The valuation methods are mixed: the relative-multiple lens lands well below the price, the earnings-power methods sit below, and only the growth lens reaches above. When the peer-multiple and earnings lenses both say the price is full relative to current returns, the bull case has to lean on the return staying near its recent high, and that is precisely the assumption reserve and catastrophe risk most threaten.

Valuation

An insurer is worth the return it earns on its capital, so the price is read off book value, not an operating multiple. At today's level the market pays about 1.6 times book and assumes Selective sustains a return on equity near 11.4%, against the roughly 13.4% it has recently earned. The assumption is within reach of the company's own record, which is what keeps the priced-in expectation broadly reasonable rather than stretched. The bet, in plain terms, is that the recent return normalizes modestly but does not collapse.

The valuation methods sit mostly at or below the price. The relative-multiple lens, which compares Selective to its insurance peers, lands furthest below the price, reflecting that the stock trades in the lower half of the peer group's price-to-book. The earnings-power methods sit below as well, and the asset-value lens lands just under the price; only the growth method reaches above it. That spread is the signature of a fairly-to-fully-priced insurer rather than a deep-value one: the market is paying about what the current return justifies, with little margin for the return to fade. If the sustained return came in at the peer-implied level rather than near its recent high, the price-to-book it supports would compress toward where the relative method lands.

The right solvency frame here is not debt and coverage but regulatory capital and payout capacity, because a P&C insurer's balance sheet is float-funded; debt is funding, not corporate leverage, and operating cash flow follows claim and premium flows. Selective's capacity to return cash rests on its underwriting profit plus its investment income, and full-year 2026 guidance frames both: a GAAP combined ratio of 96.5% to 97.5%, which is an underwriting profit of two-and-a-half to three-and-a-half cents per premium dollar, plus after-tax net investment income of $465 million. Those two streams fund the dividend and hold book value compounding. The decisive variable for the price is whether the combined ratio stays inside that band, because every point of deterioration flows straight to the return on equity the price is paying for.

Catalysts

Selective reported first-quarter 2026 results in April, with GAAP net income of $1.58 per diluted share and a combined ratio of 98.3%. Catastrophe losses contributed 6.2 points to the ratio, and the quarter carried no net prior-year casualty reserve development, an important detail given how often reserve strengthening has surprised the sector. The result missed the consensus operating estimate modestly, and the stock's reaction reflected a mix of constructive guidance and caution on reserves and personal lines.

The full-year guidance sets the bar for the rest of 2026. Management targets a GAAP combined ratio of 96.5% to 97.5%, after-tax net investment income of $465 million, an effective tax rate of 21.5%, and about 60.5 million weighted average diluted shares. The combined ratio band is the number to watch each quarter, because at these levels a single point of movement is a meaningful swing in underwriting profit, and catastrophe activity through storm season is the largest uncontrolled input.

Analyst sentiment is constructive but measured. The most recent rating is a Buy with a $95 price target, close to the current price, and the commentary pairs a positive view of the 2026 underwriting and investment outlook with caution on reserve strengthening and the personal-lines book. The recurring theme is that the underwriting franchise and rising investment income support the return, while reserve adequacy and catastrophe exposure are the risks that could pull it down.

Peer Cohorts (Per Segment, With Filing Citations)

Standard Commercial Lines (reported)

Standard Personal Lines (reported)

E&S Lines (reported)

Investments (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

SIGI Q1 2026 results, April 2026 · SIGI 2026 guidance, April 2026 · analyst note via TipRanks, 2026

View the full interactive SIGI report on boothcheck